APG Asset Management N.V. Lowers Stock Position in Teleflex Incorporated $TFX

Key Points

• APG Asset Management N.V. reduced its stake in Teleflex Incorporated by 12.8%, selling 3,602 shares to hold 24,500 shares valued at $3.13 million.
• Teleflex reported earnings of $3.73 per share for the last quarter, exceeding expectations with revenue of $780.90 million, up 4.2% year-over-year.
• CEO Liam Kelly and Director Stuart A. Randle both recently bought shares, indicating confidence in the company's performance despite current market conditions.

APG Asset Management N.V. lowered its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 12.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,500 shares of the medical technology company's stock after selling 3,602 shares during the period. APG Asset Management N.V. owned 0.06% of Teleflex worth $3,134,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. boosted its position in Teleflex by 30.2% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 556 shares of the medical technology company's stock valued at $77,000 after buying an additional 129 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its position in Teleflex by 0.7% in the first quarter. T. Rowe Price Investment Management Inc. now owns 6,216,763 shares of the medical technology company's stock valued at $859,095,000 after buying an additional 43,642 shares in the last quarter. Capital Fund Management S.A. acquired a new position in Teleflex in the 1st quarter valued at approximately $7,108,000. Humankind Investments LLC increased its position in Teleflex by 11.4% in the 1st quarter. Humankind Investments LLC now owns 1,586 shares of the medical technology company's stock valued at $219,000 after acquiring an additional 162 shares during the period. Finally, Groupama Asset Managment acquired a new position in Teleflex in the 1st quarter valued at approximately $250,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Wells Fargo & Company decreased their price target on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. Royal Bank Of Canada upped their price target on shares of Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research report on Friday, August 1st. Wall Street Zen downgraded shares of Teleflex from a "strong-buy" rating to a "buy" rating in a research report on Saturday. Morgan Stanley reduced their price objective on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research report on Monday, May 5th. Finally, Mizuho raised their price objective on shares of Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research report on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $141.57.

Teleflex Stock Up 0.3%

Shares of NYSE:TFX traded up $0.36 during trading on Monday, reaching $126.58. 440,766 shares of the stock were exchanged, compared to its average volume of 553,830. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44. Teleflex Incorporated has a 1-year low of $108.90 and a 1-year high of $249.90. The stock has a fifty day moving average of $119.22 and a two-hundred day moving average of $128.56. The firm has a market cap of $5.59 billion, a price-to-earnings ratio of 29.78, a price-to-earnings-growth ratio of 1.76 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The company had revenue of $780.90 million for the quarter, compared to analyst estimates of $771.53 million. During the same period in the prior year, the firm earned $3.42 earnings per share. Teleflex's revenue for the quarter was up 4.2% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. Research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Friday, August 15th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Friday, August 15th. Teleflex's dividend payout ratio is presently 32.00%.

Insider Activity at Teleflex

In other news, Director Gretchen R. Haggerty bought 500 shares of the stock in a transaction dated Wednesday, August 6th. The shares were bought at an average cost of $114.75 per share, with a total value of $57,375.00. Following the completion of the transaction, the director directly owned 6,305 shares of the company's stock, valued at $723,498.75. This trade represents a 8.61% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Liam Kelly bought 1,500 shares of the stock in a transaction dated Tuesday, August 5th. The shares were purchased at an average cost of $115.07 per share, for a total transaction of $172,605.00. Following the completion of the transaction, the chief executive officer directly owned 45,267 shares of the company's stock, valued at $5,208,873.69. This trade represents a 3.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 5,500 shares of company stock valued at $633,590 over the last three months. 1.40% of the stock is currently owned by company insiders.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.